Pharmaceutical Executive’s Post

Patient services programs play a pivotal role in ensuring that individuals receive the support and care they need throughout their healthcare journey. These programs, offered by pharmaceutical companies, healthcare providers, and healthcare organizations, are designed to enhance patient experiences, improve outcomes, and foster a sense of well-being. In this blog, we’ll explore the essential capabilities of patient services programs and how they positively impact patients and the healthcare ecosystem. #pss #PatientAccess #pharma #biotech https://lnkd.in/gKF927YX

🌟 Exciting insights from our CEO Jenny Ousbey who spoke at the Patient Centricity & Collaboration World Congress earlier this week! 🌍 At the event, Emma Sutcliffe spearheaded a theme of #noexcuses for progress. In that spirit, here are Jenny's six compelling reasons why patient advocacy and engagement are essential for pharmaceutical companies: 1️⃣ Patient engagement boosts participation in clinical trials and improves medicine adherence. 2️⃣ 81% of FDA approvals in 2019 relied on relevant patient experience data. 3️⃣ Engaging patients pre-launch can trim product time to market by 2.5 years. 4️⃣ 90% of doctors equate patient engagement with data, emphasizing the need for further progress. 5️⃣ Investors are increasingly prioritizing patient centricity and engagement in discussions with executives. 6️⃣ Yet, only a few companies have a Chief Patient Officer on their leadership team, indicating room for improvement. As Leonard Kish noted, patient engagement is the blockbuster drug of the century. Let's rally behind it! 💪 Join the movement by participating in the Patient Partnership Index at https://lnkd.in/esSzZQMc. The Association of the British Pharmaceutical Industry (ABPI) Healthcare Communications Association (HCA) #PatientCentricity #Pharmaceuticals #NoExcuses #Leadership

The UK's NHS is undergoing transformative changes; with shifting policies, resource constraints and growing patient needs. Now, more than ever, the pharmaceutical industry's partnership choices hold the key to maximising the impact of their engagement with the NHS and its impact on patients’ lives. Selecting the right partners is not only about aligning needs to expertise, but also about shared values, patient-centricity and a commitment to advancing medical care. Collaborations rooted in strategic alignment and a deep understanding of the NHS's challenges can yield innovative solutions that truly make a difference. At NeoHealthHub, we have been doing this for over a decade and our holistic suite of offerings enables us to support our clients with strategy through to execution. Speak to us today to understand how we could help you: https://lnkd.in/dHXCHJU #HealthcarePartnerships #NHSUK #InnovationInHealthcare #PharmaceuticalIndustry #CollaborationForChange NeoNavitas | NeoN | NeoSypher | NeoOptima

Prasanna Kumar Subbanna will be joining us at #TheMachinecon2024. He is a seasoned physician and business executive with over two decades of distinguished experience in the healthcare and pharmaceutical R&D sectors. With a profound understanding of the global value chain, his expertise spans clinical development, product launches, and bedside care, underscoring a comprehensive approach to healthcare innovation and patient outcomes. He will share his insights on "The Role of #GCCs in Healthcare Innovation" in an interesting panel Discussion. Novo Nordisk

Save the date for the 1st of March! We're inviting you to an enthralling journey through the fascinating worlds of #pharmacogenomics and #precisionmedicine. During this webinar, we'll shed light on the latest and greatest advancements and innovations that are transforming the face of modern medicine. You don't want to miss it!🧬 #pharmacy #IVPN #pharmacist

Join us on March 1st as we explore the fascinating world of pharmacogenomics. This webinar promises to be an insightful experience that will provide you with the latest updates and trends in the field. We can't wait to see you there! 😁 #pharmacogenomics #webinar #science #healthcare #IVPN Ahmed Wahid Osama Tabbara

Cencora helps partners navigate the healthcare landscape with expertise across the global pharmaceutical value chain, so that together, we can achieve outcomes never thought possible. As we evolve beyond AmerisourceBergen, every action we take is rooted in what we've always considered most important: keeping customers, their patients, and team members at the center of everything we do. See how we’re reshaping healthcare: https://ow.ly/oXoT50Qnx5i

With over 385,000 NPs across the U.S., it's clear why targeting NPs is crucial for pharmaceutical companies. Their growing influence in healthcare, from prescribing authority to roles as primary care providers and specialists, makes NPs key players in patient care decisions. Don't overlook the power of NPs in transforming patient outcomes, its easier than ever to engage NPs with Novem! #Novem #NursePractitioners #PharmaMarketing

Today at SfEE Summit; value in Pharma needs to be redefined! In today's rapidly evolving healthcare landscape, it has become increasingly clear that the traditional definition of value in the pharmaceutical industry is no longer sufficient. It is time for us to rethink our approach and redefine what value truly means in the context of healthcare. True value in pharma should encompass a broader range of factors, including patient-centricity, real-world evidence & effectiveness, and long-term sustainability. By taking a more holistic view of value, we can better meet the needs of patients, providers, and payers alike.

Navigating Pharma Payer Landscape: Identifying the Potential New Pharmacy Benefit Changes Our in-depth study is crafted to grasp the perspectives of payers and pharmacy benefit managers in light of recent legislative mandates. We delve into their potential reactions to changes and heightened cost-sharing, focusing on critical aspects: Pharmaceutical Benefit Design Changes: Exploring potential shifts in formulary restrictiveness, utilization management, and other controls. Uncover the strategic redesigns shaping the industry's future. Patient Out-of-Pocket-Cost Implications: An evaluation of how these legislative changes may impact the financial landscape for patients. Understanding the real-world implications for those at the heart of healthcare. Evolving Relationships with Pharma Manufacturers: Dive into the intricate dynamics between stakeholders. Anticipate potential changes in pricing and rebate arrangements, unlocking insights into the evolving partnerships that drive the pharmaceutical industry. Learn more about how to request your copy of this valuable market research: https://lnkd.in/ezxkD7dg